These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24854529)

  • 1. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
    Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
    Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
    Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound hypernatremia due to central diabetes insipidus.
    Vaqar A; Rafiq A; Javaid KH; Parveen R; Sadaf R
    J Coll Physicians Surg Pak; 2012 Jun; 22(6):409-11. PubMed ID: 22630107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
    Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
    Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
    Arima H; Oiso Y; Juul KV; Nørgaard JP
    Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient with essential hypernatremia had good response to desmopressin acetate therapy.
    Guo Q; Lu J; Mu Y; Dou J; Pan C
    Neuro Endocrinol Lett; 2010; 31(5):588-93. PubMed ID: 21173753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
    Almutlaq N; Eugster EA
    J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
    Smego AR; Backeljauw P; Gutmark-Little I
    J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic effect of oral desmopressin lyophilisate formulation in children with central diabetes insipidus.
    Korkmaz HA; Coşkunol F; Barışık V; Ozkan B
    J Pediatr Endocrinol Metab; 2023 Oct; 36(10):925-929. PubMed ID: 37658767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
    Non L; Brito D; Anastasopoulou C
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients.
    Juul KV; Schroeder M; Rittig S; Nørgaard JP
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2181-7. PubMed ID: 24527719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical review: Treatment of neurohypophyseal diabetes insipidus.
    Oiso Y; Robertson GL; Nørgaard JP; Juul KV
    J Clin Endocrinol Metab; 2013 Oct; 98(10):3958-67. PubMed ID: 23884783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of central diabetes insipidus with oral desmopressin in a patient with ectrodactyly and cleft lip/palate (ECP) syndrome.
    Ozaydin E; Aycan Z; Yusufoğlu AM; Cetinkaya E; Ergen S; Unal S; Köse G
    Turk J Pediatr; 2009; 51(1):89-93. PubMed ID: 19378901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Persistent central diabetes insipidus in a very low birth weight infant].
    Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
    Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin duration of antidiuretic action in patients with central diabetes insipidus.
    Juul KV; Bichet DG; Nørgaard JP
    Endocrine; 2011 Aug; 40(1):67-74. PubMed ID: 21626284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic central diabetes insipidus in an extreme premature infant: A case report.
    Biset A; Claris O
    Arch Pediatr; 2018 Nov; 25(8):480-484. PubMed ID: 30361085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
    Marín GR; Baspineiro B; Vilca I
    Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of neurogenic diabetes insipidus.
    Chanson P; Salenave S
    Ann Endocrinol (Paris); 2011 Dec; 72(6):496-9. PubMed ID: 22071315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
    Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of oral desmopressin therapy in posterior urethral valve patients with polyuria and detection of factors affecting the therapy.
    Naghizadeh S; Kefi A; Dogan HS; Burgu B; Akdogan B; Tekgul S
    Eur Urol; 2005 Nov; 48(5):819-25. PubMed ID: 15998564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.